Paul J Ciclitira
Overview
Explore the profile of Paul J Ciclitira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scherf K, Catassi C, Chirdo F, Ciclitira P, Feighery C, Gianfrani C, et al.
Front Nutr
. 2021 Jan;
7:626712.
PMID: 33511151
No abstract available.
2.
Japelj N, Suligoj T, Zhang W, Corte-Real B, Messing J, Ciclitira P
Br J Nutr
. 2020 May;
124(4):480.
PMID: 32441231
No abstract available.
3.
Scherf K, Catassi C, Chirdo F, Ciclitira P, Feighery C, Gianfrani C, et al.
Front Nutr
. 2020 Apr;
7:29.
PMID: 32258047
Celiac disease (CD) affects a growing number of individuals worldwide. To elucidate the causes for this increase, future multidisciplinary collaboration is key to understanding the interactions between immunoreactive components in...
4.
Japelj N, Suligoj T, Zhang W, Corte-Real B, Messing J, Ciclitira P
Br J Nutr
. 2020 Feb;
123(12):1382-1389.
PMID: 32100654
The only generally accepted treatment of coeliac disease (CD) is a lifelong gluten-free diet. Wheat gluten proteins include gliadins, low and high molecular weight glutenins. However, we have found significant...
5.
Suligoj T, Ciclitira P, Bozic B
J Immunol Res
. 2017 May;
2017:1042606.
PMID: 28512643
Disaccharidases (DS) are brush border enzymes embedded in the microvillous membrane of small intestinal enterocytes. In untreated coeliac disease (CD), a general decrease of DS activities is seen. This manuscript...
6.
Nasr I, Nasr I, Campling H, Ciclitira P
F1000Res
. 2016 Nov;
5.
PMID: 27803799
Refractory coeliac disease (RCD) is a recognised complication, albeit very rare, of coeliac disease (CD). This condition is described when individuals with CD continue to experience enteropathy and subsequent or...
7.
Wahab W, Suligoj T, Ellis J, Cortez-Real B, Ciclitira P
Int J Exp Pathol
. 2016 Sep;
97(4):303-309.
PMID: 27659035
Coeliac disease (CD) is an inflammatory disorder of the small intestine. It includes aberrant adaptive immunity with presentation of CD toxic gluten peptides by HLA-DQ2 or DQ8 molecules to gluten-sensitive...
8.
Landy J, Ronde E, English N, Clark S, Hart A, Knight S, et al.
World J Gastroenterol
. 2016 Mar;
22(11):3117-26.
PMID: 27003989
Inflammatory bowel diseases are characterised by inflammation that compromises the integrity of the epithelial barrier. The intestinal epithelium is not only a static barrier but has evolved complex mechanisms to...
9.
Donnelly S, Suligoj T, Ellis H, Ciclitira P
Scand J Gastroenterol
. 2016 Feb;
51(7):819-26.
PMID: 26911209
Objective: Coeliac disease affects approximately 1% of Northern American and European populations. It is caused by an inappropriate immune response to dietary gluten. Gluten comprises of two major protein fractions:...
10.
Comino I, Bernardo D, Bancel E, Moreno M, Sanchez B, Barro F, et al.
Food Nutr Res
. 2016 Feb;
60:30324.
PMID: 26853779
Background: Oats provide important nutritional and pharmacological properties, although their safety in coeliac patients remains controversial. Previous studies have confirmed that the reactivity of the anti-33-mer monoclonal antibody with different...